Nitric oxide versus epoprostenol for refractory hypoxemia in Covid-19
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0270646
Abstract: Objective To compare the efficacy and outcomes with inhaled nitric oxide (iNO) and inhaled epoprostenol (iEPO) in patients with refractory hypoxemia due to COVID-19. Design Retrospective Cohort Study. Setting Single health system multicenter academic teaching… read more here.
Keywords: refractory hypoxemia; nitric oxide; group; ino ... See more keywords